Atropine eye drops to control myopia progression
15 August 2019
Volume 20, Issue 3
This paper critically reviews scientific studies investigating the efficacy of atropine at regressing myopia progression in children.
How effective are atropine eye drops at reducing myopia progression in children? provides a critical appraisal of the literature with regard to clinical use of atropine for myopia control. Low-dose atropine is an effective pharmacological myopia control strategy. Although not yet available commercially in the UK, clinical trials are ongoing at present and the drug could be adopted in the near future for myopia control.
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
The College of Optometrists was invited to provide evidence at the parliamentary hearing on the Safer Screen Bill, a private member’s bill aimed at protecting children’s rights and well-being in the digital age.
Becky McCall analyses the evidence that working distance increases the risk of myopia in children, and the escalation of time spent on screens is related to the surging incidence of myopia around the world.
The clinical figures that count.